Minnetronix Launches Its Own Brain-Surgery Port; Mizuho Will Distribute
Minnetronix is launching MindsEye, the first expandable brain-access port for neurosurgery, through a partnership with Mizuho America. It is the first device that Minnetronix has brought to market on its own after 26 years as a contract service provider in the industry.
You may also be interested in...
New trial data shows Boston Scientific’s Sentinel cerebral embolic protection device may reduce the risk of disabling stroke, but it does not appear to reduce the overall risk of stroke.
Edwards Lifesciences is ramping up US commercialization of its Pascal Precision mitral valve transcatheter edge-to-edge repair device, the first US competitor for Abbott’s MitraClip. The FDA approved Pascal Precision earlier than the company expected, based on results of the CLASP IID trial.
Results of the CLASP IID trial showed Edwards’ Pascal mitral valve repair system was non-inferior for safety and effectiveness compared to Abbott’s MitraClip device.